Onesource Specialty Pharma Complete Financial Statements

In FY2025, Onesource Specialty Pharma (ONESOURCE) reported revenue ₹379 Cr, net profit ₹11 Cr and EPS ₹0.92, with a net profit margin of 2.9% and ROE of 0.2%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Onesource Specialty Pharma share price today.

6 Years of Data
2025 - 2020

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.90% 2025 data
EBITDA Margin 29.02% 2025 data
Operating Margin 28.00% 2025 data
Return on Assets 0.15% 2025 data
Return on Equity 0.19% 2025 data

Balance Sheet Ratios

Current Ratio 1.95 2025 data
Equity Ratio 77.89% 2025 data
Asset Turnover 0.05 2025 data

ONESOURCE Revenue, Net Profit & EBITDA — Year-on-Year Growth

ONESOURCE YoY (Sept 2024 vs Sept 2025) — revenue +12.1%, net profit +126.2%, EBITDA +44.7%, expenses +2.3%.

Revenue Growth
+12.1%
Year-over-Year
Net Profit Growth
+126.2%
Year-over-Year
EBITDA Growth
+44.7%
Year-over-Year
Expense Growth
+2.3%
Year-over-Year
Assets Growth
+476.8%
Year-over-Year
Equity Growth
+1385.1%
Year-over-Year
Operating Cash Flow Growth
+36.4%
Year-over-Year
Investing Cash Flow Growth
-139.3%
Year-over-Year
Financing Cash Flow Growth
+205.4%
Year-over-Year

ONESOURCE Income Statement — Revenue, EBITDA & Net Profit

Onesource Specialty Pharma revenue ₹379 Cr, EBITDA ₹110 Cr, net profit ₹11 Cr, EPS ₹0.92 (2025) — net profit margin 2.9%. Explore ONESOURCE investment value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Jun 2023 Dec 2023
Revenue 379 429 333 295 338 76 296 399 34 10 88
Expenses 269 244 242 280 263 76 233 351 105 80 173
EBITDA 110 185 91 15 76 0 64 48 -71 -70 -85
Operating Profit Margin % 28.00% 43.00% 26.00% 4.00% 21.00% -4.00% 20.00% 11.00% -210.00% -800.00% -207.00%
Depreciation 70 69 68 70 68 20 68 69 18 19 20
Interest 34 33 28 38 45 21 42 46 25 18 26
Profit Before Tax 6 83 -4 -93 -38 -40 -47 -67 -114 -107 -130
Tax -5 -16 -4 -4 5 0 -41 2 0 0 0
Net Profit 11 99 0 -89 -42 -40 -6 -69 -114 -107 -130
Earnings Per Share (₹) 0.92 8.61 -0.02 -7.74 -10.13 -9.67 -0.51 -6.31 -27.37 0.00 -31.32

ONESOURCE Balance Sheet — Assets, Liabilities & Shareholders' Equity

ONESOURCE total assets ₹7,550 Cr, total equity ₹5,881 Cr, total liabilities ₹ Cr (2025) — ROE 0.2%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 7,550 1,309 2,009 2,442 1,258 972
Current Assets 1,086 176 228 511 99 25
Fixed Assets 6,118 863 1,361 1,231 633 354
Capital Work in Progress 218 188 335 490 431 543
Investments 16 20 5 0 0 0
Other Assets 1,199 238 309 722 195 75
LIABILITIES
Total Liabilities
Current Liabilities 556 282 358 621 321 361
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 5,881 396 786 1,013 776 417
Share Capital 11 4 4 3 2 1
Reserves & Surplus 5,869 392 781 1,009 775 414

ONESOURCE Cash Flow Statement — Operating, Investing & Financing

Onesource Specialty Pharma operating cash flow ₹-68 Cr, investing ₹-201 Cr, financing ₹412 Cr, net cash flow ₹143 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities -68 -107 -163 -416 -118
Investing Activities -201 511 -68 -692 -207
Financing Activities 412 -391 118 1,162 381
Net Cash Flow 143 13 -112 55 56